Psychiatry
Psychiatry Sites Nationwide
Advancing Psychiatry Research
At DelRicht Research, we have a specialized network of sites focused on psychiatry, offering unrivaled patient access and investigator support for your research programs. Our commitment to advancing psychiatry research is reflected in our partnerships with leading physicians and healthcare facilities.
Therapeutic Expertise
Our expertise in psychiatry research includes, but is not limited to:
- Mood Disorders: Major Depressive Disorder (MDD), Treatment-Resistant Depression (TRD), Bipolar Disorder, Bipolar Depression
- Anxiety Disorders: Generalized Anxiety Disorder (GAD), Social Anxiety Disorder, Post-traumatic Stress Disorder (PTSD)
- Agitation & Behavioral: Schizophrenia, Acute Agitation in Bipolar Disorder, Agitation Associated with Alzheimer’s Disease
- Neurodevelopmental: Adult and Childhood ADHD, Autism Spectrum Disorder (Behavioral Symptom Targets)
- Psychedelic: Psychedelic-Assisted Therapy (LSD, Psilocybin Analogs)
- Addiction & Substance Use Disorders: Alcohol Use Disorder (AUD), Substance Abuse Disorders
x4 Sites Recognized as Top Enroller Status
x1 First Patient Screened or Enrolled
Capabilities
DelRicht Research’s broad network provides access to diverse psychiatry patients and supports high-quality studies with experienced physicians and staff. Key capabilities include:
- DEA License and CDS Registration
- Secure Investigational Product Storage (Including Controlled Substances)
- Simulated Home Environment Treatment Rooms
- Audio/Visual Monitored Treatment Rooms
- Infusion-Experienced Staff
- Studies on Cognitive Behavioral Therapy
- Substance Abuse Treatment Programs
- Digital and Telepsychiatry Interventions
- Audio/Visual Monitored Investigational Product Storage Rooms
- Security Cloud Backup Storage for Security Cameras within IP Storage and Treatment Rooms
- Structured Psychiatric Diagnostic Interviews (e.g., MINI, SCID)
- Experienced Staff Trained on Validated Psychiatric Rating Scales (MADRS, HAM-D, YMRS, PANSS, CGI-S/I)
- Cognitive Testing (MoCA, RBANS, MMSE)
- Long-Acting Injectable Administration (Antipsychotics, Antidepressants)
- Inpatient and Outpatient Trial Management
- Central Rater and Remote Assessment Coordination
- Patient-Reported Outcomes via ePRO and EMA Platforms
- Suicide Risk Monitoring and Safety Protocols (C-SSRS)
- Substance Use and Dependence Trial Experience (Alcohol, Cannabis, Opioid)
- Tracking System to Monitor Medical Equipment, Location, Calibration, Usage, and Maintenance
- Training Tracking System to Monitor Study Staff and Site Certifications and Licensure
6 Psychiatry Principal Investigators
90+ Years of Collective PI Experience
Meet Some Of Our Investigators

Caroline Campion, MD
Board Certified, Psychiatry

Jay Italiya, MD
Board Certified, Psychiatry

Patrice Mann, MD
Board Certified, Psychiatry
Case Studies & Trial Highlights
Enrolled 467%
in a Phase 3 Major Depressive Disorder (MDD) Trial
First Site
Activated and 2nd Patient Screened in a Phase 4 MDD Trial
Enrolled 183%
in a Phase 4 ADHD Trial for Children Ages 4-12
Psychiatry
Site Network of Choice
See Our Psychiatry Locations
